In the News
Perioperative SSRIs may raise risk of adverse events
Selective serotonin reuptake inhibitors (SSRIs) taken in the perioperative period may increase the risk for adverse events, a new study suggests.
Azithromycin not associated with increased cardiovascular risk in the general population
Azithromycin was not associated with an increased risk of death from cardiovascular causes in a general population of young and middle-aged adults, a Danish study found.
Guideline update addresses new P2Y12 inhibitors for unstable angina, NSTEMI
Two major cardiology organizations released a focused update to their guideline for managing patients with unstable angina (UA) and non-ST-elevation myocardial infarction (NSTEMI), in part to address research on new antiplatelets.
Guidance released on use of new oral anticoagulants in nonvalvular afib
The European Heart Rhythm Association (EHRA) published guidance last week on using new oral anticoagulants in patients with nonvalvular atrial fibrillation (AF).
New limitations on tolvaptan due to liver injury risk
The labeling for tolvaptan (Samsca) has been revised due to observation of increased risk of liver injury in recent trials, the FDA announced last week.
New option approved for reversal of anticoagulation
An alternative to plasma (Prothrombin Complex Concentrate, Human; brand name, Kcentra) was approved by the FDA last week for the urgent reversal of vitamin K antagonist (VKA) anticoagulation in adults with acute major bleeding.
Put words in our mouth
ACP HospitalistWeekly wants readers to create captions for our new cartoon and help choose the winner. Pen the winning caption and win a $50 gift certificate good toward any ACP product, program or service.